Marminon C[au] - Search Results

Year	Number of Results
2002	3
2003	3
2008	1
2010	1
2012	1
2013	1
2014	1
2015	2
2017	2
2018	3
2019	2
2020	2
2021	4
2022	1
2023	1

1

Synthesis, in silico study (DFT, ADMET) and crystal structure of novel sulfamoyloxy-oxazolidinones: Interaction with SARS-CoV-2.

Bouzina A, Berredjem M, Bouacida S, Bachari K, Marminon C, Borgne ML, Bouaziz Z, Bouone YO. Bouzina A, et al. Among authors: marminon c. J Mol Struct. 2022 Jun 5;1257:132579. doi: 10.1016/j.molstruc.2022.132579. Epub 2022 Feb 5. J Mol Struct. 2022. PMID: 35153333 Free PMC article.

2

Ninhydrins inhibit carbonic anhydrases directly binding to the metal ion.

Bouzina A, Berredjem M, Nocentini A, Bua S, Bouaziz Z, Jose J, Le Borgne M, Marminon C, Gratteri P, Supuran CT. Bouzina A, et al. Among authors: marminon c. Eur J Med Chem. 2021 Jan 1;209:112875. doi: 10.1016/j.ejmech.2020.112875. Epub 2020 Oct 5. Eur J Med Chem. 2021. PMID: 33059188

3

Mechanistic basis of breast cancer resistance protein inhibition by new indeno[1,2-b]indoles.

Kita DH, Guragossian N, Zattoni IF, Moure VR, Rego FGM, Lusvarghi S, Moulenat T, Belhani B, Picheth G, Bouacida S, Bouaziz Z, Marminon C, Berredjem M, Jose J, Gonçalves MB, Ambudkar SV, Valdameri G, Le Borgne M. Kita DH, et al. Among authors: marminon c. Sci Rep. 2021 Jan 19;11(1):1788. doi: 10.1038/s41598-020-79892-w. Sci Rep. 2021. PMID: 33469044 Free PMC article.

4

Uncompetitive nanomolar dimeric indenoindole inhibitors of the human breast cancer resistance pump ABCG2.

Guragossian N, Belhani B, Moreno A, Nunes MT, Gonzalez-Lobato L, Marminon C, Berthier L, Rocio Andrade Pires AD, Özvegy-Laczka C, Sarkadi B, Terreux R, Bouaziz Z, Berredjem M, Jose J, Di Pietro A, Falson P, Le Borgne M. Guragossian N, et al. Among authors: marminon c. Eur J Med Chem. 2021 Feb 5;211:113017. doi: 10.1016/j.ejmech.2020.113017. Epub 2020 Nov 12. Eur J Med Chem. 2021. PMID: 33223263

5

Inhibition of Shiga toxin-converting bacteriophage development by novel antioxidant compounds.

Bloch S, Nejman-Faleńczyk B, Pierzynowska K, Piotrowska E, Węgrzyn A, Marminon C, Bouaziz Z, Nebois P, Jose J, Le Borgne M, Saso L, Węgrzyn G. Bloch S, et al. Among authors: marminon c. J Enzyme Inhib Med Chem. 2018 Dec;33(1):639-650. doi: 10.1080/14756366.2018.1444610. J Enzyme Inhib Med Chem. 2018. PMID: 29536772 Free PMC article.

6

Broad-Spectrum Anticancer Activity and Pharmacokinetic Properties of a Prenyloxy-Substituted Indeno[1,2-b]indole Derivative, Discovered as CK2 Inhibitor.

El-Awaad E, Birus R, Marminon C, Bouaziz Z, Ballentin L, Aichele D, Le Borgne M, Jose J. El-Awaad E, et al. Among authors: marminon c. Pharmaceuticals (Basel). 2021 Jun 5;14(6):542. doi: 10.3390/ph14060542. Pharmaceuticals (Basel). 2021. PMID: 34198928 Free PMC article.

7

Synthesis, Spectroscopic Characterization, and In Vitro Antibacterial Evaluation of Novel Functionalized Sulfamidocarbonyloxyphosphonates.

Bouzina A, Bechlem K, Berredjem H, Belhani B, Becheker I, Lebreton J, Le Borgne M, Bouaziz Z, Marminon C, Berredjem M. Bouzina A, et al. Among authors: marminon c. Molecules. 2018 Jul 10;23(7):1682. doi: 10.3390/molecules23071682. Molecules. 2018. PMID: 29996552 Free PMC article.

8

Self-Assembled Supramolecular Nanoparticles Improve the Cytotoxic Efficacy of CK2 Inhibitor THN7.

Nacereddine A, Bollacke A, Róka E, Marminon C, Bouaziz Z, Fenyvesi F, Bácskay IK, Jose J, Perret F, Le Borgne M. Nacereddine A, et al. Among authors: marminon c. Pharmaceuticals (Basel). 2018 Jan 26;11(1):10. doi: 10.3390/ph11010010. Pharmaceuticals (Basel). 2018. PMID: 29373552 Free PMC article.

9

QSAR Model of Indeno[1,2-b]indole Derivatives and Identification of N-isopentyl-2-methyl-4,9-dioxo-4,9-Dihydronaphtho[2,3-b]furan-3-carboxamide as a Potent CK2 Inhibitor.

Haidar S, Marminon C, Aichele D, Nacereddine A, Zeinyeh W, Bouzina A, Berredjem M, Ettouati L, Bouaziz Z, Le Borgne M, Jose J. Haidar S, et al. Among authors: marminon c. Molecules. 2019 Dec 26;25(1):97. doi: 10.3390/molecules25010097. Molecules. 2019. PMID: 31888043 Free PMC article.

10

Preparation and characterization of CK2 inhibitor-loaded cyclodextrin nanoparticles for drug delivery.

Perret F, Marminon C, Zeinyeh W, Nebois P, Bollacke A, Jose J, Parrot-Lopez H, Le Borgne M. Perret F, et al. Among authors: marminon c. Int J Pharm. 2013 Jan 30;441(1-2):491-8. doi: 10.1016/j.ijpharm.2012.11.004. Epub 2012 Nov 13. Int J Pharm. 2013. PMID: 23154152

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results